期刊文献+

西洋参干预胰岛素抵抗大鼠活性部位的化学成分研究Ⅳ 被引量:4

The Study on the Chemical Constituents of Rats'Active Site for Impacting Insulin Resistance by American Ginseng
下载PDF
导出
摘要 目的:研究西洋参干预胰岛素抵抗大鼠活性部位的化学成分。方法:以乙醇提取,用大孔树脂吸附,乙醇洗脱得其总皂苷,再用硅胶柱色谱及HPLC等分离技术与方法进行分离和纯化,并通过理化常数及光谱数据确定其结构。结果与结论:分得3个化合物,鉴定后分别为3-O-β-D-吡喃葡萄糖基-(1→2)-β-D-吡喃葡萄糖基-20-O-β-D吡喃葡萄糖基-(1→6)-β-D-吡喃葡萄糖基-达玛-24-稀-3,β12,β20S-三醇(Ⅰ);3-O-β-D-吡喃葡萄糖基-(1→2)-β-D-吡喃葡萄糖基-20-O-β-D吡喃葡萄糖基-(1→6)-β-D-吡喃葡萄糖基-达玛-24-稀-3,β12,β20R-三醇(Ⅱ);3-O-β-D-吡喃葡萄糖基-(1→2)-β-D-吡喃葡萄糖基-20-O-β-D吡喃阿拉伯糖基-(1→6)-β-D-吡喃葡萄糖基-达玛-24烯-3,β12,β20R-三醇(Ⅲ)。 Objective:To study the chemical constituents of rats'active site for impacting insulin resistance by American ginseng.Methods:They were extracted by ethanol and adsorbed by macroreticular resins,then eluted with ethanol and isolated by silicagel column chromatography and HPLC preparation chromatography.Their structures were determined by physical and chemical properties,as well as spectrographical identification.Result and conclusion: Three compounds were isolated from the active site.Their structures were identified as 3-O-β-D-glucopyranosyl-(1→2)-β-glucopyra-nosyl-20-O-β-glucopyranosy1-(1→6)-β-D-glucopyranosyl-dammar-24-ene-3β,12β,20S-triol(Ⅰ),3-O-β-D-glucopyranosyl-(1→2)-β-glucopyra-nosyl-20-O-β-glucopyranosy1-(1→6)-β-D-glucopyranosyl-dammar-24-ene-3β,12β,20R-triol(Ⅱ),3-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyl-20-O-β-D-arabinopyranosyl-(1→6)-β-D-glucopyranosy1-dammar-24-ene-3β,12β,20R-triol(Ⅲ).
出处 《中医药学报》 CAS 2011年第1期74-76,共3页 Acta Chinese Medicine and Pharmacology
基金 国家自然科学基金项目(编号:30672632) 黑龙江省杰出青年科学基金项目(编号:JC04-01) 黑龙江省博士科学基金(编号:LRB09-321) 黑龙江省留学回国人员科技项目择优资助基金
关键词 西洋参 活性部位 胰岛素抵抗 化学成分 American ginseng Active Site Insulin Resistance Chemical Constituents
  • 相关文献

参考文献5

二级参考文献15

  • 1李冀,马育轩,葛鹏玲,盛波,刘微.西洋参治疗胰岛素抵抗大鼠活性部位对骨骼肌转运蛋白-4mRNA表达的影响[J].中医药学报,2009,37(5):9-11. 被引量:3
  • 2李冀,马育轩,葛鹏玲,石鑫,吴全娥.西洋参干预胰岛素抵抗大鼠活性部位的化学成分研究[J].中医药学报,2009,37(6):68-70. 被引量:3
  • 3徐伟斌,俞璐,罗敏.抵抗素的研究进展[J].国际内分泌代谢杂志,2006,26(1):23-25. 被引量:18
  • 4Sowers JR, Frohlich ED. Insulin and insulin resistance:impact on blood pressure and cardiovascular disease [ J ]. Med Clin North Am, 2004,88(1 ) :63 -82.
  • 5Steppan CM, Bailey ST, Bhat S, et al. The hormone resistance links obesity to diabetes[J]. Nature,2001,50(9) :2094 -2099.
  • 6Boden G. Role of fatty acid in the pathogenesis of insulin resisuance and NIDDM[J]. Diabetes, 1997,46( 1 ) :3.
  • 7Lee Y, Hirose H, Ohneda M, et al. β - cell lipotoxicity in the pathogenesis of non - insulin - dependent diabetes mdlitus of obese rats: impairment in adipocyteβ - cell relationships [ J ]. Proe Natl Acad Sci USA,1994,91 (23) :10878.
  • 8Gong H, Ni Y, Guo X, et al. Resistin promotes 333 -L1 preadipocyte differentiaion [ J ]. Eur J Endocrinol,2004 ( 150 ) :885.
  • 9Rajala M W,Qi Y,patel H R,et al. Regulation of resistin expression and circulating levels in obesity, diabetesandfasting [ J ]. Diabetes, 2004(53) :1671.
  • 10Reaven GM.Role of insulin resistance in human diseases[J].Diabetes,1988,37(12):1595-1607.

共引文献10

同被引文献16

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部